• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流式细胞术在骨髓增生异常综合征中的应用:陷阱与技术考量

Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.

作者信息

Alhan Canan, Westers Theresia M, Cremers Eline M P, Cali Claudia, Ossenkoppele Gert J, van de Loosdrecht Arjan A

机构信息

Department of Hematology, Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Cytometry B Clin Cytom. 2016 Jul;90(4):358-67. doi: 10.1002/cyto.b.21333. Epub 2015 Dec 14.

DOI:10.1002/cyto.b.21333
PMID:26517178
Abstract

The application of flow cytometry (FC) is recommended as part of the diagnostic approach for MDS. The complexity of flow cytometric analysis of bone marrow cells in MDS has been an obstacle for general application. However, in the past years several studies showed practical flow cytometric approaches for the diagnosis and prognosis of MDS. In this report we discuss technical considerations and highlight issues that require special attention when handling and analyzing bone marrow samples of patients with cytopenia and suspicion of MDS. © 2015 Clinical Cytometry Society.

摘要

推荐将流式细胞术(FC)的应用作为骨髓增生异常综合征(MDS)诊断方法的一部分。MDS中骨髓细胞流式细胞术分析的复杂性一直是其广泛应用的障碍。然而,在过去几年中,多项研究展示了用于MDS诊断和预后评估的实用流式细胞术方法。在本报告中,我们讨论技术要点,并强调在处理和分析血细胞减少且怀疑患有MDS患者的骨髓样本时需要特别关注的问题。© 2015临床细胞计量学会

相似文献

1
Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.流式细胞术在骨髓增生异常综合征中的应用:陷阱与技术考量
Cytometry B Clin Cytom. 2016 Jul;90(4):358-67. doi: 10.1002/cyto.b.21333. Epub 2015 Dec 14.
2
The role of flow cytometric immunophenotyping in myelodysplastic syndromes.流式细胞术免疫表型分析在骨髓增生异常综合征中的作用。
Ann N Y Acad Sci. 2006 Nov;1089:383-94. doi: 10.1196/annals.1386.031.
3
Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.流式细胞术免疫表型分析在骨髓增生异常评估中的应用。
Cytometry B Clin Cytom. 2011 Jul-Aug;80(4):201-11. doi: 10.1002/cyto.b.20607. Epub 2011 Jun 14.
4
Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.儿童难治性血细胞减少症的流式细胞术骨髓免疫表型分析
Haematologica. 2015 Mar;100(3):315-23. doi: 10.3324/haematol.2014.107706. Epub 2014 Nov 25.
5
[The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].流式细胞术检测骨髓细胞免疫表型在骨髓增生异常综合征诊断中的作用
Postepy Hig Med Dosw (Online). 2008 Jul 23;62:354-63.
6
Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.多参数流式细胞术有助于区分骨髓增生异常综合征与非肿瘤性血细胞减少症。
Eur J Cancer. 2016 Feb;54:49-56. doi: 10.1016/j.ejca.2015.11.013. Epub 2015 Dec 22.
7
A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.一种用于骨髓增生异常综合征诊断和预后评估的多参数流式细胞术免疫表型评分系统。
Clin Lab. 2012;58(11-12):1241-51.
8
[Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].[流式细胞术免疫表型分析在骨髓增生异常综合征诊断中的作用——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1477-81.
9
High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.高流式细胞术评分可在骨髓增生异常综合征修订国际预后评分系统中识别不良预后亚组。
Br J Haematol. 2014 Oct;167(1):100-9. doi: 10.1111/bjh.12994. Epub 2014 Jun 30.
10
Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation.通过质谱细胞术对骨髓增生异常综合征进行分析,显示祖细胞表型和分化异常。
Cytometry B Clin Cytom. 2020 Mar;98(2):131-145. doi: 10.1002/cyto.b.21860. Epub 2020 Jan 9.

引用本文的文献

1
Advances in Microflow Cytometry-Based Molecular Detection Methods for Improved Future MDS Cancer Diagnosis.基于微流控细胞术的分子检测方法进展,以改善未来骨髓增生异常综合征癌症诊断
Curr Issues Mol Biol. 2024 Jul 26;46(8):8053-8070. doi: 10.3390/cimb46080476.
2
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.多发性骨髓瘤流式细胞术临床报告共识:融合实验室经验与临床需求的多中心协调过程
Cancers (Basel). 2023 Mar 30;15(7):2060. doi: 10.3390/cancers15072060.
3
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
流式细胞术分析骨髓增生异常:分析前和技术问题-欧洲白血病网络的建议。
Cytometry B Clin Cytom. 2023 Jan;104(1):15-26. doi: 10.1002/cyto.b.22046. Epub 2021 Dec 11.
4
Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes.计算流式细胞术作为疑似骨髓增生异常综合征的诊断工具。
Cytometry A. 2021 Aug;99(8):814-824. doi: 10.1002/cyto.a.24360. Epub 2021 May 12.
5
Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.探讨骨髓增生异常综合征和骨髓增生异常/骨髓增殖性肿瘤中的 blast 成分:通过评估原始细胞异质性和干细胞异常,CD45RA 和 CD371 可提高流式细胞术的诊断价值。
Cytometry B Clin Cytom. 2021 Sep;100(5):574-589. doi: 10.1002/cyto.b.21983. Epub 2020 Dec 24.
6
The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).特发性血细胞减少症的临床挑战(ICUS)和克隆性血细胞减少症的临床挑战(CCUS)。
Curr Hematol Malig Rep. 2019 Dec;14(6):536-542. doi: 10.1007/s11899-019-00547-3.
7
Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes.多参数流式细胞术在骨髓增生异常综合征中的临床意义。
Pathobiology. 2019;86(1):14-23. doi: 10.1159/000490727. Epub 2018 Sep 18.
8
The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review.流式细胞术在骨髓增生异常综合征中的应用:综述
Front Oncol. 2017 Nov 15;7:270. doi: 10.3389/fonc.2017.00270. eCollection 2017.